Abstract
Objective To study the clinical effect and safety of paliperidone extended-release tablets in the treatment of schizophrenia. Methods 80 patients with schizophrenia were selected as the research subjects.According to randomized single blind, the patients were divided into two groups, 40 cases in each group.The control group was given risperidone treatment, the observation group used paliperidone extended-release tablets treatment.The total effective rate, positive and negative symptoms score (PANSS score), mental disability score (WHO-DAS score II) and the incidence of adverse reactions were compared between the two groups. Results The clinical total effective rate (95.00%) in the observation group was significantly higher than the control group (80.00%, χ2=4.114, P 0.05). Conclusion The clinical efficacy of paliperidone extended-release tablets in the treatment of schizophrenia is significant, which can effectively relieve patients with mental disorders, and it is safe and reliable. Key words: Schizophrenia; Paliperidone extended-release tablets; Risperidone; Safety
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.